Cargando…
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
BACKGROUND: During venovenous extracorporeal membrane oxygenation (vvECMO), direct thrombin inhibitors are considered by some potentially advantageous over unfractionated heparin (UFH). We tested the hypothesis that Argatroban is non-inferior to UFH regarding thrombosis and bleeding during vvECMO. M...
Autores principales: | Fisser, Christoph, Winkler, Maren, Malfertheiner, Maximilian V., Philipp, Alois, Foltan, Maik, Lunz, Dirk, Zeman, Florian, Maier, Lars S., Lubnow, Matthias, Müller, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081564/ https://www.ncbi.nlm.nih.gov/pubmed/33910609 http://dx.doi.org/10.1186/s13054-021-03581-x |
Ejemplares similares
-
Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
por: Lubnow, Matthias, et al.
Publicado: (2022) -
Recirculation in single lumen cannula venovenous extracorporeal membrane oxygenation: A non-randomized bi-centric trial
por: Fisser, Christoph, et al.
Publicado: (2022) -
Corrigendum: Recirculation in single lumen cannula venovenous extracorporeal membrane oxygenation: A non-randomized bi-centric trial
por: Fisser, Christoph, et al.
Publicado: (2022) -
Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010) -
Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)